scholarly journals Pharmacological Treatment Options for Panic Disorder in Children and Adolescents

2007 ◽  
Vol 12 (2) ◽  
pp. 1-6
Author(s):  
Gabriele Masi ◽  
Cinzia Pari ◽  
Stefania Millepiedi
Keyword(s):  
Panic Disorder ◽  
Children And Adolescents ◽  
Pharmacological Treatment ◽  
Treatment Options

Anxiety disorders in primary care

2017 ◽  
Author(s):  
Markus Dold ◽  
Siegfried Kasper
Keyword(s):  
Anxiety Disorder ◽  
Social Anxiety ◽  
Panic Disorder ◽  
Anxiety Disorders ◽  
Generalized Anxiety Disorder ◽  
Social Anxiety Disorder ◽  
Pharmacological Treatment ◽  
Treatment Options ◽  
Specific Phobia ◽  
Generalized Anxiety

Chapter 7 summarizes the epidemiology, clinical characteristics, and evidence for pharmacological treatment options of generalized anxiety disorder, panic disorder, agoraphobia, specific phobia, and social anxiety disorder. With regard to the pharmacological management, serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) represent the well-established first-line medication for generalized anxiety disorder (GAD), panic disorder, agoraphobia, and social anxiety disorder. In GAD, also the calcium channel modulator pregabalin can be regarded as evidence-based treatment option. In simple cases of specific phobia, however, the initiation of a pharmacotherapy is not recognized as standard treatment according to international treatment guidelines and psychotherapeutic interventions should be preferred. Besides illustrating the pharmacological treatment options, we described the actualized diagnostic criteria for anxiety disorders established in the newly introduced fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V).

scholarly journals Evidence-based pharmacological treatment options for ADHD in children and adolescents

2021 ◽  
pp. 107940
Author(s):  
Konstantin Mechler ◽  
Tobias Banaschewski ◽  
Sarah Hohmann ◽  
Alexander Häge
Keyword(s):  
Children And Adolescents ◽  
Pharmacological Treatment ◽  
Treatment Options ◽  
Evidence Based

scholarly journals Prevalence of Metabolic Syndrome in Children and Adolescents with Type 1 Diabetes Mellitus and Possibilities of Prevention and Treatment: A Systematic Review

Nutrients ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1782
Author(s):  
Monika Grabia ◽  
Renata Markiewicz-Żukowska ◽  
Katarzyna Socha
Keyword(s):  
Systematic Review ◽  
Metabolic Syndrome ◽  
Type 1 Diabetes ◽  
Children And Adolescents ◽  
Treatment Options ◽  
Overweight And Obesity ◽  
Excess Body Weight ◽  
Healthy Population ◽  
Prevention And Treatment

Overweight and obesity are an increasingly common problem, not only among the healthy population, but also in adolescents with type 1 diabetes (T1DM). Excess body weight is related to many cardiometabolic complications as well as a high risk of metabolic syndrome (MetS). The purpose of this systematic review is to provide a concise and critical overview of the prevalence of MetS in children and adolescents with T1DM and, ultimately, to discuss prevention and treatment options. The study was conducted in accordance with PRISMA guidelines. This review shows that, apart from the growing percentage of overweight and obese children and adolescents with T1DM (on average 20.1% and 9.5%, respectively), the problem of the increasing incidence of MetS (range from 3.2 to 29.9%, depending on the criteria used) is one of the most important phenomena of our time. One of the methods of prevention and treatment is a combined approach: changing eating habits and lifestyle, but there are also reports about the beneficial effects of the gut microflora.

Response to pharmacological treatment of psychosensorial symptoms in patients with panic disorder

1997 ◽  
Vol 42 (1) ◽  
pp. 29S-30S
Author(s):  
C. Toni ◽  
S. Ramacciotti ◽  
B. Simonetti ◽  
E. De Soricellis ◽  
T. Xuereb ◽  
...  
Keyword(s):  
Panic Disorder ◽  
Pharmacological Treatment

scholarly journals The safety of pharmacological treatment options for lupus nephritis

2016 ◽  
Vol 15 (8) ◽  
pp. 1041-1054 ◽  
Author(s):  
Alba Velo-García ◽  
Eleana Ntatsaki ◽  
David Isenberg
Keyword(s):  
Lupus Nephritis ◽  
Pharmacological Treatment ◽  
Treatment Options
Sign in / Sign up

Export Citation Format

Share Document